Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aebi

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
ESMO Real World Data and Digital Oncology|April 3, 2026
Corrigendum to "Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life": ESMO Real World Data And Digital Oncology, volume 8 (2025), 100140S Zimmermann, S Aebi, O Gautschi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2011
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)K Zaman, B Thürlimann, J Huober, et al.
Cancer Research|July 1, 1996
Loss of DNA mismatch repair in acquired resistance to cisplatinS Aebi, B Kurdi-Haidar, R Gordon, et al.
Cancer Research|May 15, 1997
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repairD Fink, H Zheng, S Nebel, et al.
Leukemia & Lymphoma|October 24, 2000
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemiaT Pabst, U R Peters, M Tinguely, et al.
International Journal of Cancer|August 30, 2000
Differential expression of p73 splice variants and protein in benign and malignant ovarian tumoursD Zwahlen, M P Tschan, T J Grob, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2015
The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06)F Strasser, D Blum, R von Moos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemiaU Novak, T J Grob, G Baskaynak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
Lancet (London, England)|June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?S Aebi, S Gelber, M Castiglione-Gertsch, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
ESMO Real World Data and Digital Oncology|April 3, 2026
Corrigendum to "Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life": ESMO Real World Data And Digital Oncology, volume 8 (2025), 100140S Zimmermann, S Aebi, O Gautschi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 18, 2011
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)K Zaman, B Thürlimann, J Huober, et al.
Cancer Research|July 1, 1996
Loss of DNA mismatch repair in acquired resistance to cisplatinS Aebi, B Kurdi-Haidar, R Gordon, et al.
Cancer Research|May 15, 1997
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repairD Fink, H Zheng, S Nebel, et al.
Leukemia & Lymphoma|October 24, 2000
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemiaT Pabst, U R Peters, M Tinguely, et al.
International Journal of Cancer|August 30, 2000
Differential expression of p73 splice variants and protein in benign and malignant ovarian tumoursD Zwahlen, M P Tschan, T J Grob, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2015
The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06)F Strasser, D Blum, R von Moos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemiaU Novak, T J Grob, G Baskaynak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-upM Colleoni, Z Sun, G Martinelli, et al.
Lancet (London, England)|June 24, 2000
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?S Aebi, S Gelber, M Castiglione-Gertsch, et al.
Pageof 8